This video was recorded November 27, 2023 during the LiveLung SCLC virtual monthly meeting.
About the Speaker Badri Rengarajan, MD
Medical Director in Solid Tumors, Jazz Pharmaceuticals
Badri Rengarajan, MD serves as a medical director in solid tumors at Jazz Pharmaceuticals, where he covers Zepzelca (lurbinectedin) and various pipeline candidates. Dr. Rengarajan helped launch Zepzelca (lurbinectedin) in small cell lung cancer and currently supports several medical affairs activities, including product/brand strategy, market research, investigator-initiated trials, clinical development studies, and real-world evidence/health economics projects. He previously served as medical affairs lead for the ASPIRE unit at Actelion Pharmaceuticals. He’s held roles in healthcare modeling and analytics, product development strategy & new product planning, regulatory affairs, market research, and business development. In his extracurricular time, he serves on the board of a nonprofit foundation assisting patients with two ultra-rare autoimmune skin diseases. Dr. Rengarajan earned an A.B. in Biology and Public Policy from Harvard University and an M.D. from Yale University.
The LiveLung Small Cell Lung Cancer Program is supported in-part by grants from AstraZeneca, Amgen, and Jazz Pharmaceutical.
This Video Content has been made available for informational and educational purposes only. The Video Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on the Site.
LiveLung and speakers hereby disclaim any and all liability to any party for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising directly or indirectly from any use of the Video Content, which is provided as is, and without warranties.